Categories : Endocrine & Metabolic
Product Packaging : 10 / 30 tablets
Product Composition : 10 mg, 25 mg
Send MessageEmpagliflozin Tablets are an advanced oral antidiabetic medication belonging to the SGLT2 inhibitor class, specifically formulated to enhance glycemic control in adults with type 2 diabetes mellitus. This mechanism works by blocking glucose reabsorption in the kidneys, thereby promoting urinary glucose elimination and reducing blood sugar levels independently of insulin action.
In addition to its glucose-lowering effect, Empagliflozin is clinically recognized for its cardiovascular and renal protective benefits, making it a preferred therapy in patients with diabetes associated with heart disease or kidney complications. Its multi-benefit profile supports its growing role in comprehensive cardiometabolic management.
Genliva Wellness LLP, Himatnagar, India, is a trusted empagliflozin tablet manufacturer India pharma and SGLT2 inhibitor tablets exporter India, delivering premium-quality, WHO-GMP compliant formulations to global pharmaceutical markets, hospitals, and distributors.
Empagliflozin Tablets are SGLT2 inhibitor medications used to help control blood glucose levels in patients with type 2 diabetes mellitus. They work by promoting the removal of excess glucose through urine and support overall metabolic health.
These tablets are commonly used for the treatment of type 2 diabetes mellitus along with diet and exercise. They help improve glycemic control and support long-term diabetes management.
Empagliflozin Tablets provide effective glucose control with additional cardiovascular and metabolic support, improving patient convenience and treatment outcomes.
